Eurofins Scientific SE (ETR:ESF0)
Germany · Delayed Price · Currency is EUR 67.22
-1.34 (-1.95%)
At close: Feb 26, 2026
Eurofins Scientific SE Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 474.8 | 406.4 | 310.2 | 610.2 | 782.6 |
Depreciation & Amortization | 654.8 | 632.7 | 621.3 | 580.5 | 520.7 |
Other Amortization | 4.6 | 4.8 | 4.7 | 3.8 | 7.3 |
Loss (Gain) From Sale of Assets | 8.9 | 23.6 | 1.8 | -141.4 | 0.1 |
Asset Writedown & Restructuring Costs | 77.4 | 76 | 72.8 | 41.7 | 27.6 |
Loss (Gain) on Equity Investments | -0.3 | -1 | -0.4 | -0.9 | -2 |
Stock-Based Compensation | 19.8 | 21.8 | 23.3 | 22.9 | 22.2 |
Other Operating Activities | 107.8 | 110.7 | 49 | -11.7 | 171.4 |
Change in Accounts Receivable | -44.5 | 37.2 | -43.4 | 79.9 | -195.7 |
Change in Inventory | 1.4 | 3.6 | 11 | 16 | 2.8 |
Change in Accounts Payable | 25 | -25.9 | -41.3 | -12 | 85.6 |
Change in Unearned Revenue | 26.3 | -3 | 10.2 | 20.2 | 26.3 |
Change in Other Net Operating Assets | 42.9 | 32 | -1.3 | -72.9 | 68.8 |
Operating Cash Flow | 1,399 | 1,319 | 1,018 | 1,136 | 1,511 |
Operating Cash Flow Growth | 6.07% | 29.57% | -10.42% | -24.82% | 23.53% |
Capital Expenditures | -759.9 | -453.6 | -478.1 | -576.1 | -444.4 |
Sale of Property, Plant & Equipment | 14.2 | 10.2 | 6.4 | 14.9 | 24.8 |
Cash Acquisitions | -261.4 | -343.4 | -158.1 | -430 | -530.6 |
Divestitures | -2.8 | -0.9 | 7.3 | 215.3 | -2 |
Sale (Purchase) of Intangibles | -74.9 | -74.8 | -72 | -84.1 | -62 |
Investment in Securities | -2 | -3.3 | 1.9 | 1.5 | -8.4 |
Other Investing Activities | 10.6 | 19.3 | 11.5 | 2.6 | 1.6 |
Investing Cash Flow | -1,076 | -846.5 | -681.1 | -855.9 | -1,021 |
Long-Term Debt Issued | 1,222 | 118 | 638.5 | 633.9 | 826.3 |
Long-Term Debt Repaid | -504.9 | -670.1 | -270.5 | -249 | -1,433 |
Net Debt Issued (Repaid) | 716.9 | -552.1 | 368 | 384.9 | -607.1 |
Issuance of Common Stock | 397 | 0.2 | 601.5 | 14.6 | 35.8 |
Repurchase of Common Stock | -940.5 | -271.9 | -238.5 | -433.1 | -3.6 |
Common Dividends Paid | -157.4 | -149.1 | -233.9 | -228 | -166.1 |
Other Financing Activities | -117.6 | -116.6 | -83.5 | -49.7 | -169.3 |
Financing Cash Flow | -101.6 | -1,090 | 413.6 | -311.3 | -910.3 |
Foreign Exchange Rate Adjustments | -46.6 | 9.4 | -12.7 | -0.8 | 24.3 |
Miscellaneous Cash Flow Adjustments | 0.1 | - | - | -0.1 | 0.1 |
Net Cash Flow | 174.6 | -607.7 | 737.7 | -31.8 | -395.5 |
Free Cash Flow | 639 | 865.3 | 539.8 | 560.2 | 1,067 |
Free Cash Flow Growth | -26.15% | 60.30% | -3.64% | -47.50% | 16.91% |
Free Cash Flow Margin | 8.76% | 12.45% | 8.29% | 8.35% | 15.88% |
Free Cash Flow Per Share | 3.43 | 4.45 | 2.73 | 2.81 | 5.32 |
Cash Interest Paid | 115.5 | 114.2 | 82.2 | 49.4 | 168.8 |
Cash Income Tax Paid | 188.8 | 160.7 | 139.7 | 296.1 | 296.7 |
Levered Free Cash Flow | 492.53 | 810.56 | 511.9 | 500.79 | 875.49 |
Unlevered Free Cash Flow | 584.11 | 897.33 | 584.33 | 554.24 | 922.81 |
Change in Working Capital | 51.1 | 43.9 | -64.8 | 31.2 | -18.5 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.